Real world data is transforming clinical research, augmenting existing randomized controlled trial data to reduce risks and improve generalizability. With regulators setting clearer standards for ...
The US Food and Drug Administration (FDA) on Tuesday released new draft guidance clarifying how it plans to determine cases when real-world data may be sufficient for use in premarket and postmarket ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results